mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |